Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus

Korean Circulation Journal

Volumn 42, Issue 2, 2012, Pages 100-106

  Choi, Kyu Young ^a   Kim, Dong Bin ^a   Kim, Myung Jun ^a   Kwon, Bum June ^a   Chang, Seo Yoon ^a   Jang, Sung Won ^a   Cho, Eun Joo ^a   Rho, Tai Ho ^a   Kim, Jae Hyung ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Coronary artery disease; Diabetes mellitus; Thrombospondin 1

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOSPONDIN 1;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROTEIN BLOOD LEVEL; RISK;

EID: 84863297914     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2012.42.2.100     Document Type: Article

References (28)

1. Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971;68:240-3.
2. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995;130:503-6.
3. Adams JC. Thrombospondins: multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 2001;17:25-51. (Pubitemid 33096170)
4. Ren B, Yee KO, Lawler J, Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 2006;1765:178-88.
5. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/ TSP2-null mice. Am J Pathol 2002;161:831-9. (Pubitemid 34988370)
6. Frangogiannis NG, Ren G, Dewald O, et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005;111:2935-42. (Pubitemid 40814186)
7. Isenberg JS, Romeo MJ, Abu-Asab M, et al. Increasing survival of ischemic tissue by targeting CD47. Circ Res 2007;100:712-20. (Pubitemid 46594886)
8. Stenina OI, Krukovets I, Wang K, et al. Increased expression of thrombospondin-1 in vessel wall of diabetic zucker rat. Circulation 2003;107:3209-15. (Pubitemid 36793093)
9. Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI. Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem 2007;282:5704-14. (Pubitemid 47093782)
10. Murphy M, Godson C, Cannon S, et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274:5830-4. (Pubitemid 29109239)
11. Tada H, Kawai H, Ishii H, Nomura K, Urayama T, Isogai S. Thrombospondin modulates adhesion, proliferation and production of extracellular matrix in mesangial cells. Tohoku J Exp Med 1995;177:293-302. (Pubitemid 26128227)
12. Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE. Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 2000;157:1353-63.
13. Yevdokimova N, Wahab NA, Mason RM. Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 2001;12:703-12. (Pubitemid 32246698)
14. Belmadani S, Bernai J, Wei CC, et al. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 2007;171:777-89. (Pubitemid 47440977)
15. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes care 1997;20:1183-97.
16. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72. (Pubitemid 37430158)
17. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. (Pubitemid 13187192)
18. Majack RA, Goodman LV, Dixit VM. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol 1988;106:415-22. (Pubitemid 18052189)
19. Stouffer GA, Hu Z, Sajid M, et al. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 1998;97:907-15. (Pubitemid 28113930)
20. Kirma C, Akcakoyun M, Esen AM, et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J 2007;71:698-702. (Pubitemid 46683360)
21. Hsu SC, Volpert OV, Steck PA, et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 1996;56:5684-91. (Pubitemid 26422173)
22. Nor JE, Mitra RS, Sutorik MM, Mooney DJ, Castle VP, Polverini PJ. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 2000;37: 209-18. (Pubitemid 30350890)
23. McGillicuddy FC, O'Toole D, Hickey JA, Gallagher WM, Dawson KA, Keenan AK. TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol 2006;44:469-75. (Pubitemid 43766672)
24. Topol FJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 2001;104:2641-4.
25. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002;347:1916-23. (Pubitemid 35429921)
26. Carlson CB, Liu Y, Keck JL, Mosher DF. Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability. J Biol Chem 2008;283:20069-76.
27. Stenina OI. Regulation of vascular genes by glucose. Curr Pharm Des 2005;11:2367-81. (Pubitemid 40872702)
28. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.